PROVIDER PROFILE · NPI 1861822769

Bach-Cuc TranPA-C

PRACTICEFOREFRONT DERMATOLOGY, S.C.See all providers at this practice →

Physician AssistantSugar Land, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

811

Unique beneficiaries

—

Total services

1,203

Distinct HCPCS

Medicare payment

$40K

Peer benchmark

Total Medicare services vs. 6,198 Physician Assistant providers in TX — top quintile (cohort median 254).

PRESCRIBING · PART D · 2024

Total Rx claims

2,603

Beneficiaries

—

Total drug cost

$146K

Distinct drugs

Brand share

16.6%

Top prescribed drugs

Atorvastatin Calcium122 claims

Rosuvastatin Calcium102 claims

Levothyroxine Sodium94 claims

Amlodipine Besylate68 claims

Prednisone66 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$1K

Payment records

By payment type

Food and Beverage$1K

REFERRAL NETWORK

Where Bach-Cuc Tran's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX	172	367
Marsha Hughart Internal Medicine · Houston, TX	15	27
Bhakti Gidvani Pulmonary Disease · Houston, TX	15	32
SCHULTZ, ROGER	13	27
Rosella Creed Dermatology · Richmond, TX	12	20
MANLEY, LAUREN	11	27
METHODIST HEALTH CENTERS	11	14

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history